Search
TELA Bio Inc
TELAAdd to Watchlist
0.970USD
+0.065+7.18%
Close 09-11 16:00（ET）
42.59MMarket Cap
LossP/E TTM
TELA Bio Inc (TELA) Stock Price Target & Forecast
Analyst Rating
Based on 5 analysts giving stock ratings to TELA Bio Inc in the past month.
Buy
1 Strong Buy
3 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
2.100USD+116.49%
TELA Analyst Recommendation Trends
In the current month, TELA has received 3 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. TELA average Analyst price target in the last month is 2.100.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
1
1
1
1
1
1
1
1
3
3
3
3
3
3
3
3
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
5
5
5
5
5
5
5
TELA Analyst Rating for Peer Comparison
Updated: Sep 13, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Stryker Corp
SYK
11
13
6
0
0
30
Medtronic PLC
MDT
9
10
11
0
0
30
Dexcom Inc
DXCM
13
13
4
0
0
30
Zimmer Biomet Holdings Inc
ZBH
2
6
21
0
0
29
Abbott Laboratories
ABT
11
12
6
0
0
29
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Insulet Corp
PODD
7
8
12
0
0
27
Guardant Health Inc
GH
12
13
2
0
0
27
Repligen Corp
RGEN
5
14
3
0
0
22
Tandem Diabetes Care Inc
TNDM
4
8
10
0
0
22
Financial Forecasting
Based on analysts' estimates, TELA EPS is projected to reach -0.146 in FY2026Q3, following reported EPS of -0.196 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.18
-0.19
-0.18
-0.15
-0.12
Actual
-0.17
-0.21
-0.20
--
--
Surprise
+4.30%
-13.89%
-10.07%
--
--
FAQs
What is TELA Bio Inc's expected revenue for the next quarter?
TELA Bio Inc's expected revenue is 20.04M.
What is TELA Bio Inc's price target?
Analysts forecast that TELA Bio Inc's price target is USD 2.10, with the highest forecast at USD 3.00 and the lowest forecast at USD 1.00.
How have TELA Bio IncTELA's recent earnings per share performed?
The market expectation was USD -0.20, while TELA Bio IncTELA's earnings per share (EPS) for the previous quarter was USD -0.21. EPS for the next quarter is expected at USD -0.15.
What is the analyst rating for TELA Bio Inc?
Based on the ratings of TELA Bio Inc's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.